Oncology & Cancer
SENTI-202: Ready-made immune therapy found to be effective against leukemia
A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.
Apr 28, 2025
0
1
Leukemia
Medications
Statin use may improve survival in patients with some blood cancers
Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their ...
Apr 23, 2025
0
0
Oncology & Cancer
A new druggable cancer target: RNA-binding proteins on the cell surface
In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs. Extending this discovery ...
Apr 23, 2025
0
41
Oncology & Cancer
Reprogramming cancer cells to treat an aggressive type of leukemia
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
Apr 16, 2025
0
2
Oncology & Cancer
Rapid growth of blood cancer driven by a single genetic 'hit'
A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in life and how fast it grows. Researchers reveal explosive growth rates of cancerous cells years before ...
Apr 9, 2025
0
0
Oncology & Cancer
CAR-M technology: A novel approach to overcome CAR-T limitations in solid tumor treatment
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments. The work is published in the journal Biomarker Research.
Apr 9, 2025
0
62
Oncology & Cancer
HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantation
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer ...
Apr 2, 2025
0
0
Medications
Blood cancer patients on Bruton's tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
Apr 1, 2025
0
0
Oncology & Cancer
CAR T-cell therapy tricks cancer cells with decoy, increases treatment efficiency in B-cell acute lymphoblastic leukemia
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any ...
Mar 24, 2025
0
1
Oncology & Cancer
Scoring system helps predict risk of developing cancer from common blood disorder in older adults
A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.
Mar 19, 2025
0
0
